🇺🇸 FDA

Company profile · Sponsor

Jiangsu

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

C79E88C · NMPA biotech CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Jiangsu (C79E88C) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C79E88C
Exchange NMPA
Company type biotech
Headquarters CN

Pipeline (1)

Search pipeline →

  1. KN046

    Jiangsu

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Jiangsu?

Jiangsu (C79E88C) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Jiangsu sponsor?

We track 1 ClinicalTrials.gov-linked program for Jiangsu, including KN046. Open each program for phase, modality, NCT IDs, and indication details.

Where does Jiangsu company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.